Fingerprint
Dive into the research topics of 'A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies
Darren C. Phillips, Sha Jin, Gareth P. Gregory, Qi Zhang, John Xue, Xiaoxian Zhao, Jun Chen, Yunsong Tong, Haichao Zhang, Morey Smith, Stephen K. Tahir, Rick F. Clark, Thomas D. Penning, Jennifer R. Devlin, Jake Shortt, Eric D. Hsi, Daniel H. Albert, Marina Konopleva, Ricky W. Johnstone, Joel D. Leverson
Research output: Contribution to journal › Article › peer-review
52
Scopus
citations